Your browser is no longer supported. Please, upgrade your browser.
Settings
SPPI Spectrum Pharmaceuticals, Inc. daily Stock Chart
SPPI [NASD]
Spectrum Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.09 Insider Own5.30% Shs Outstand79.92M Perf Week13.54%
Market Cap589.81M Forward P/E- EPS next Y-0.71 Insider Trans0.00% Shs Float72.35M Perf Month21.18%
Income-82.20M PEG- EPS next Q-0.26 Inst Own70.20% Short Float10.49% Perf Quarter11.65%
Sales131.70M P/S4.48 EPS this Y-20.20% Inst Trans4.41% Short Ratio10.59 Perf Half Y70.05%
Book/sh2.77 P/B2.66 EPS next Y34.30% ROA-19.20% Target Price10.00 Perf Year8.37%
Cash/sh1.72 P/C4.29 EPS next 5Y- ROE-35.00% 52W Range3.21 - 8.00 Perf YTD66.59%
Dividend- P/FCF- EPS past 5Y-25.30% ROI-17.80% 52W High-7.75% Beta1.52
Dividend %- Quick Ratio3.20 Sales past 5Y-5.40% Gross Margin70.20% 52W Low129.91% ATR0.24
Employees227 Current Ratio3.40 Sales Q/Q-33.70% Oper. Margin-58.30% RSI (14)72.16 Volatility4.11% 3.99%
OptionableYes Debt/Eq0.45 EPS Q/Q-105.80% Profit Margin-62.40% Rel Volume2.09 Prev Close7.38
ShortableYes LT Debt/Eq0.45 EarningsMay 02 AMC Payout- Avg Volume717.22K Price7.38
Recom1.30 SMA2017.11% SMA5014.40% SMA20038.42% Volume1,500,748 Change0.00%
Feb-10-17Resumed Jefferies Buy
Nov-05-15Reiterated RBC Capital Mkts Outperform $13 → $12
Aug-07-15Reiterated RBC Capital Mkts Outperform $12 → $13
Apr-02-15Initiated FBR Capital Outperform $9
Feb-23-15Downgrade ROTH Capital Buy → Neutral $15 → $7
Jul-15-14Upgrade R. F. Lafferty Sell → Neutral $7.50
Oct-07-13Initiated HC Wainwright Buy $15
May-29-13Initiated Burrill Institutional Research Mkt Outperform $12
Mar-13-13Reiterated RBC Capital Mkts Outperform $19 → $16
Mar-13-13Downgrade WallachBeth Buy → Sell $20 → $5.50
May-02-11Reiterated MLV Capital Buy $12.50 → $20.50
Mar-25-11Initiated RBC Capital Mkts Outperform $12
Dec-07-10Reiterated Morgan Joseph Buy $8 → $10
Jan-12-10Upgrade Morgan Joseph Hold → Buy $8
Oct-14-09Reiterated Rodman & Renshaw Mkt Outperform $10 → $8
Sep-08-09Downgrade Morgan Joseph Buy → Hold
Sep-09-08Initiated Morgan Joseph Buy $5
Apr-23-08Downgrade Oppenheimer Outperform → Perform
Mar-18-08Downgrade Brean Murray Buy → Hold
Nov-01-07Reiterated Friedman Billings Mkt Perform $5.50 → $4
Jun-20-17 04:32PM  Top 4 Small-Cap Stocks for 2017 Investopedia
Jun-19-17 07:00AM  Spectrum Pharmaceuticals Highlights Results of a Combination Study of FOLOTYN® (pralatrexate injection) Plus Romidepsin Presented at the 14th International Conference on Malignant Lymphoma (14-ICML) Meeting Business Wire
Jun-12-17 02:57PM  Spectrum Pharmaceuticals, Inc. Value Analysis (NASDAQ:SPPI) : June 12, 2017 Capital Cube
Jun-09-17 08:35AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SPPI-US : June 9, 2017 Capital Cube
Jun-02-17 07:00AM  Spectrum Pharmaceuticals Highlights Three Abstracts of Clinical Data at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, June 2-6, 2017 Business Wire
May-30-17 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2017 Global Healthcare Conference on June 6th Business Wire
May-19-17 03:11PM  Edited Transcript of SPPI earnings conference call or presentation 2-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-16-17 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2017 Health Care Conference on May 17 Business Wire
May-08-17 05:15PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : May 8, 2017 Capital Cube
May-05-17 10:29AM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q1, 2017 By the Numbers : May 5, 2017 Capital Cube
08:55AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SPPI-US : May 5, 2017 Capital Cube
May-04-17 01:36PM  Edited Transcript of SPPI earnings conference call or presentation 2-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-03-17 01:04PM  Why Spectrum Pharmaceuticals Stock Is Sinking Today Motley Fool -11.55%
10:09AM  Biotech Movers: Myriad Genetics, Spectrum Pharmaceuticals, Array BioPharma TheStreet.com
May-02-17 06:06PM  Spectrum Pharma reports 1Q loss Associated Press
04:02PM  Spectrum Pharmaceuticals Reports First Quarter 2017 Financial Results and Pipeline Update Business Wire
Apr-27-17 04:17PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : April 27, 2017 Capital Cube
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 42nd Annual Deutsche Bank Health Care Conference on May 4 Business Wire
Apr-25-17 07:00AM  Spectrum Pharmaceuticals Announces First Quarter 2017 Financial Results Teleconference and Webcast Business Wire
Apr-21-17 07:30AM  Today's Research Reports on Biotech Stocks to Watch: Celldex Therapeutics and Spectrum Pharmaceuticals Accesswire
Apr-14-17 08:04AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SPPI-US : April 14, 2017 Capital Cube
Apr-07-17 05:30PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : April 7, 2017 Capital Cube
Apr-04-17 07:00AM  Spectrum Pharmaceuticals Highlights Preclinical Data of ROLONTIS (eflapegrastim) at the American Association for Cancer Research (AACR) Annual Meeting Business Wire
07:00AM  Spectrum Pharmaceuticals Highlights Preclinical Data of ROLONTIS (eflapegrastim) at the American Association for Cancer Research (AACR) Annual Meeting
Mar-31-17 09:09AM  Spectrum (SPPI) Initiates Phase II Study for Cancer Candidate Zacks
09:09AM  Spectrum (SPPI) Initiates Phase II Study for Cancer Candidate
07:00AM  Spectrum Pharmaceuticals Highlights Three Abstracts on ROLONTIS (eflapegrastim) and BELEODAQ® (belinostat) for injection at the American Association for Cancer Research (AACR) Annual Meeting in Washington, D.C., April 1-5, 2017 Business Wire
07:00AM  Spectrum Pharmaceuticals Highlights Three Abstracts on ROLONTIS (eflapegrastim) and BELEODAQ® (belinostat) for injection at the American Association for Cancer Research (AACR) Annual Meeting in Washington, D.C., April 1-5, 2017
Mar-30-17 07:00AM  Spectrum Pharmaceuticals Announces Initiation of a Phase 2 Trial of Poziotinib in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations Business Wire
Mar-18-17 01:04PM  SPECTRUM PHARMACEUTICALS INC Financials
Mar-14-17 05:32PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
Mar-10-17 04:06PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers +5.12%
Mar-09-17 10:58AM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017 Capital Cube
10:58AM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017
10:07AM  Biotech Premarket Movers: Spectrum, BioCryst, Curis TheStreet.com
10:07AM  Biotech Premarket Movers: Spectrum, BioCryst, Curis
09:15AM  Spectrum (SPPI) Q4 Loss Narrower than Expected, Sales Beat Zacks
09:15AM  Spectrum (SPPI) Q4 Loss Narrower than Expected, Sales Beat
Mar-08-17 04:32PM  Spectrum Pharma reports 4Q loss Associated Press
04:32PM  Spectrum Pharma reports 4Q loss
04:06PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:02PM  Spectrum Pharmaceuticals Reports Fourth Quarter 2016 and Full Year 2016 Financial Results and Pipeline Update Business Wire
07:07AM  Q4 2016 Spectrum Pharmaceuticals Inc Earnings Release - After Market Close
Mar-06-17 06:34PM  Can Epizyme (EPZM) Spring a Surprise This Earnings Season?
06:32PM  AVEO Pharmaceuticals (AVEO) Q4 Earnings: What's in Store?
10:06AM  Semtech (SMTC) to Report Q4 Earnings: Will it Disappoint?
08:50AM  Should You Buy Spectrum Pharmaceuticals (SPPI) Ahead of Earnings?
Mar-01-17 07:00AM  Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial Results Teleconference and Webcast Business Wire +5.16%
Feb-27-17 11:20AM  Spectrum Pharma Sued Again For 'Misleading Investors at Investopedia +8.02%
Feb-16-17 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 2017 RBC Capital Markets Global Healthcare Conference on February 23rd Business Wire
Jan-20-17 02:03PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : January 20, 2017
Jan-09-17 06:02AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Dec-20-16 02:31PM  Is Steel Partners Holdings LP (SPLP) A Good Stock To Buy According To Other Hedge Funds? at Insider Monkey
Dec-14-16 01:35PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : December 14, 2016
Dec-12-16 09:48AM  Should You Avoid Spectrum Pharmaceuticals, Inc. (SPPI)? at Insider Monkey
Dec-09-16 05:11AM  These small-cap stocks are expected to rise at least 31% in 2017 at MarketWatch +6.73%
Dec-08-16 07:00AM  Spectrum Pharmaceuticals Highlights Promising Preclinical Data Evaluating Poziotinib in Lung Cancer at the 17th IASLC World Conference on Lung Cancer Business Wire
Dec-06-16 07:00AM  Spectrum Pharmaceuticals Highlights Survival Advantage in a Case Match Control Analysis of the PROPEL Study with FOLOTYN® (pralatrexate injection) at the 58th Annual Meeting of the American Society of Hematology (ASH) Business Wire
Dec-05-16 01:05PM  10 Major Pharma and FDA Catalysts Coming in December at 24/7 Wall St.
07:00AM  Spectrum Pharmaceuticals Highlights Five Abstracts on ROLONTIS (eflapegrastim) and Poziotinib at the San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas, December 6-10, 2016 Business Wire
Dec-02-16 07:00AM  Spectrum Pharmaceuticals Highlights Four Abstracts at the 58th Annual Meeting of the American Society of Hematology (ASH) in San Diego, California, December 3-6, 2016 Business Wire
Nov-29-16 03:15PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Spectrum Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors Accesswire
07:24AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SPPI-US : November 29, 2016
Nov-28-16 12:30PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : November 28, 2016 -5.31%
Nov-23-16 06:31AM  Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzola
Nov-22-16 11:14AM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 22, 2016
Nov-21-16 08:55AM  Spectrum Bladder Cancer Drug Nixed by FDA (SPPI) at Investopedia +5.85%
07:24AM  Spectrum (SPPI) Gets CRL for Bladder Cancer Drug in U.S.
Nov-18-16 12:06PM  3-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
11:04AM  SPPI UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Shareholders of a Class Action Involving Spectrum Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of November 21, 2016 PR Newswire
06:22AM  Spectrum Pharma says U.S. FDA rejects its bladder cancer drug Reuters
06:01AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Nov-17-16 11:47AM  UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:30AM  Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming November 21st Deadline in the Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. Business Wire
07:00AM  Spectrum Pharmaceuticals Announces Poziotinib Data Presentation at the 17th IASLC World Conference on Lung Cancer in Vienna, Austria, December 4-7, 2016 Business Wire
Nov-16-16 11:39AM  APPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) & Lead Plaintiff Deadline: November 21, 2016 GlobeNewswire
Nov-15-16 02:26PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : November 15, 2016 -8.14%
09:13AM  Spectrum (SPPI) Reports Narrower-than-Expected Q3 Loss
Nov-14-16 04:23PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire +6.44%
02:22PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Spectrum Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2016 Business Wire
11:50AM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
10:10AM  Final Opportunity For Spectrum Pharmaceuticals Shareholders To Apply For Lead Plaintiff Status In Pending Securities Fraud Lawsuit Accesswire
07:54AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SPPI-US : November 14, 2016
07:52AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
07:25AM  Spectrum Pharma reports 3Q loss
07:00AM  Spectrum Pharmaceuticals Provides Third Quarter Financial Update Business Wire
Nov-09-16 05:24PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire +15.79%
02:40PM  SPPI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Shareholders of a Class Action Involving Spectrum Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of November 21, 2016 Business Wire
02:18PM  Upcoming Deadline For Spectrum Pharmaceuticals Shareholders To Apply For Lead Plaintiff Status In Pending Securities Fraud Lawsuit Accesswire
01:52PM  SPPI LOSS ALERT: Rosen Law Firm Reminds Spectrum Pharmaceuticals, Inc. Investors of Important November 21 Deadline in Class Action Filed by Firm- SPPI GlobeNewswire
Nov-08-16 11:07AM  SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
10:25AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) & Lead Plaintiff Deadline: November 21, 2016 Accesswire
09:30AM  SPECTRUM PHARMACEUTICALS INVESTOR REMINDER: Hagens Berman Reminds Spectrum Pharmaceuticals Inc. Investors of the Lead Plaintiff Deadline in Securities Class Action GlobeNewswire
Nov-04-16 12:46PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire +9.32%
11:40AM  SPPI INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Shareholders of a Class Action Involving Spectrum Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of November 21, 2016 GlobeNewswire
Nov-03-16 04:09PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements -7.74%
04:05PM  Spectrum Pharmaceuticals Provides Third Quarter Financial and Pipeline Update Business Wire
02:16PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
10:19AM  SHAREHOLDER ALERT- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) & Lead Plaintiff Deadline: November 21, 2016 Accesswire
Spectrum Pharmaceuticals, Inc. develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer and rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor to treat patients with relapsed or refractory PTCL; ZEVALIN injection for patients with follicular non-Hodgkin's lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for patients with relapsed or refractory PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It is also developing ROLONTIS for chemotherapy-induced neutropenia; QAPZOLA for intravesical instillation in post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer; and POZIOTINIB for treating breast and lung cancer. The company sells its drugs through a direct sales force in the United States; and through distributors in Europe. Spectrum Pharmaceuticals, Inc. has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG, Sloan-Kettering Institute, and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan, Inc.; collaboration agreement with Nippon Kayaku Co., LTD.; licensing and collaboration agreement with Onxeo DK; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.